文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

间充质基质细胞保护脓毒症存活小鼠血脑屏障、减少星形胶质细胞增生并预防认知行为改变

Mesenchymal Stromal Cells Protect the Blood-Brain Barrier, Reduce Astrogliosis, and Prevent Cognitive and Behavioral Alterations in Surviving Septic Mice.
PubMed 文献 · Crit Care Med · 2020-01-01
一句话结论小鼠实验性脓毒症中,间充质基质细胞治疗可保护血脑屏障完整性、减少星形胶质细胞增生和神经炎症,并改善存活者的认知与行为。

该研究为前瞻性随机对照动物实验,用盲肠结扎穿孔诱导脓毒症雄性Swiss Webster小鼠(n=309),所有动物接受液体复苏(皮下注射生理盐水1 mL/只)和抗生素(美罗培南10 mg/kg腹腔注射,于6、24、48小时给药)。术后6小时经静脉给予间充质基质细胞(1×10细胞/0.05 mL生理盐水/只)或生理盐水(0.05 mL静脉)。间充质基质细胞未改变临床评分或生存率,但降低全身白细胞介素-1β、白细胞介素-6和单核细胞趋化蛋白-1水平;第15天存活小鼠的认知行为任务显示,间充质基质细胞减轻了空间与厌恶记忆缺陷及焦虑样行为,并减少血脑屏障功能障碍、星形胶质细胞活化及脑内炎症介质水平。

要点

  • 脓毒症小鼠术后6小时静脉给予间充质基质细胞(1×10细胞/0.05 mL生理盐水/只)未改变临床评分或生存率。
  • 间充质基质细胞降低脓毒症小鼠全身白细胞介素-1β、白细胞介素-6和单核细胞趋化蛋白-1水平。
  • 第15天存活脓毒症小鼠出现空间与厌恶记忆缺陷及焦虑样行为,间充质基质细胞减轻这些认知行为改变。
  • 间充质基质细胞减少血脑屏障功能障碍、星形胶质细胞活化及脑内白细胞介素-1β、白细胞介素-6、肿瘤坏死因子-α和白细胞介素-10水平。
  • 体外脂多糖刺激的原代星形胶质细胞中,间充质基质细胞条件培养基减少星形胶质细胞增生、白细胞介素-1β和单核细胞趋化蛋白-1,提示旁分泌机制。

适用人群与场景

  • 雄性Swiss Webster小鼠(n=309),通过盲肠结扎穿孔诱导实验性脓毒症,假手术动物作为对照。
  • 所有动物接受液体复苏(皮下注射生理盐水1 mL/只)和抗生素(美罗培南10 mg/kg腹腔注射,于6、24、48小时给药)。

处置流程与药物剂量

  • 术后6小时经静脉给予间充质基质细胞(1×10细胞/0.05 mL生理盐水/只)或生理盐水(0.05 mL静脉)。
  • 所有动物接受液体复苏(皮下注射生理盐水1 mL/只)和抗生素(美罗培南10 mg/kg腹腔注射,于6、24、48小时给药)。

研究设计与关键结果

  • 研究类型为前瞻性、随机、对照实验研究,样本量309只雄性Swiss Webster小鼠,地点为政府附属研究实验室。
  • 第1天,盲肠结扎穿孔小鼠临床评分和血浆炎症介质水平升高;间充质基质细胞未改变临床评分或生存率,但降低全身白细胞介素-1β、白细胞介素-6和单核细胞趋化蛋白-1水平。
  • 第15天,存活盲肠结扎穿孔小鼠表现出空间与厌恶记忆缺陷及焦虑样行为,可能与血脑屏障通透性增加、紧密连接信使RNA表达改变、脑内炎症介质水平升高及星形胶质细胞增生(第3天诱导)有关。
  • 间充质基质细胞减轻上述认知行为改变,并减少血脑屏障功能障碍、星形胶质细胞活化及脑内白细胞介素-1β、白细胞介素-6、肿瘤坏死因子-α和白细胞介素-10水平。
  • 体外脂多糖刺激的原代星形胶质细胞中,间充质基质细胞条件培养基减少星形胶质细胞增生、白细胞介素-1β和单核细胞趋化蛋白-1,提示旁分泌作用机制。

证据类型、等级与局限

  • 证据类型:前瞻性、随机、对照实验研究(动物实验)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Survivors of sepsis are frequently left with significant cognitive and behavioral impairments. These complications derive from nonresolving inflammation that persists following hospital discharge. To date, no study has investigated the effects of mesenchymal stromal cell therapy on the blood-brain barrier, astrocyte activation, neuroinflammation, and cognitive and behavioral alterations in experimental sepsis.

DESIGN: Prospective, randomized, controlled experimental study.

SETTING: Government-affiliated research laboratory.

SUBJECTS: Male Swiss Webster mice (n = 309).

INTERVENTIONS: Sepsis was induced by cecal ligation and puncture; sham-operated animals were used as control. All animals received volume resuscitation (1 mL saline/mouse subcutaneously) and antibiotics (meropenem 10 mg/kg intraperitoneally at 6, 24, and 48 hours). Six hours after surgery, mice were treated with mesenchymal stromal cells IV (1 × 10 cells in 0.05 mL of saline/mouse) or saline (0.05 mL IV).

MEASUREMENTS AND MAIN RESULTS: At day 1, clinical score and plasma levels of inflammatory mediators were increased in cecal ligation and puncture mice. Mesenchymal stromal cells did not alter clinical score or survival rate, but reduced levels of systemic interleukin-1β, interleukin-6, and monocyte chemoattractant protein-1. At day 15, survivor mice completed a battery of cognitive and behavioral tasks. Cecal ligation and puncture mice exhibited spatial and aversive memory deficits and anxiety-like behavior. These effects may be related to increased blood-brain barrier permeability, with altered tight-junction messenger RNA expression, increased brain levels of inflammatory mediators, and astrogliosis (induced at day 3). Mesenchymal stromal cells mitigated these cognitive and behavioral alterations, as well as reduced blood-brain barrier dysfunction, astrocyte activation, and interleukin-1β, interleukin-6, tumor necrosis factor-α, and interleukin-10 levels in vivo. In cultured primary astrocytes stimulated with lipopolysaccharide, conditioned media from mesenchymal stromal cells reduced astrogliosis, interleukin-1β, and monocyte chemoattractant protein-1, suggesting a paracrine mechanism of action.

CONCLUSIONS: In mice who survived experimental sepsis, mesenchymal stromal cell therapy protected blood-brain barrier integrity, reduced astrogliosis and neuroinflammation, as well as improved cognition and behavior.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Silva AYO, Amorim ÉA, Barbosa-Silva MC, et al. Mesenchymal Stromal Cells Protect the Blood-Brain Barrier, Reduce Astrogliosis, and Prevent Cognitive and Behavioral Alterations in Surviving Septic Mice. Crit Care Med. 2020. PMID: 32205619. doi:10.1097/CCM.0000000000004219

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。